Providing support for the maintenance of assets, ensuring the unhindered operational performance of services based at Abzena's Cambridge UK site.

Providing project management/leadership skills to advance a variety antibody development pipeline activities in collaboration with Abcams RabMAb discovery platform, operated in Hangzhou. This included the progression of optimisation approaches and the delivery of outcomes to conclude specialist projects.

Experienced scientific manager progressing through various roles of Team Leader, Alliance Manager and Operations Manager, based on skills and knowledge acquired through the development and application of Isogenica's in vitro CIS display technology for biologics discovery.Provided leadership for the Commercial Services Team, project managing Isogenica's commercial and collaborative alliances delivering early stage biologics for pharma clients and proof of concept technology development projects for both commercial and academic collaborators.Supported business development activities through presentations and technical input to scope out and formulate commercial project strategies as well as developing initial sales contact opportunities.Previously at Isogenica:COO Jan 2015 - Sept 2016Operations Manager Jan 2012 - Dec 2014Alliances Manager Feb 2009 - Dec 2011Senior Scientist May 2005 - Jan 2009

Contributed to research aimed at determining the validity of alternative chip surface coatings and the optimisation of procedures to allow the consistent generation of solid phase PCR colonies essential for the success of the sequencing-by-synthesis approach currently employed in Illumina’s next generation sequencing instruments.

Responsible for assisting in the transfer and establishment of a ribosome display technology, developed by Dr Mingyue He of the Babraham Institute, in the commercial setting of a newly spun-out biotech company.Leader of a small team of scientists involved in the application of ribosome display for the discovery of target-binding antibody fragments through the panning and screening of molecular selection outputs.Generation of a naïve antibody fragment library by assembly of RT-PCR derived fragments amplified from mRNA purified from the PBMCs of multiple random donors.

Leader of a Biotechnology Team involved in the design and application of recombinant strategies for herbicide and fungicide screening in high throughput assay systems.Recommendation and implementation of molecular technology to drive and support research within the fungicide/herbicide discovery process. This included the development of molecular approaches for the identification, genetic validation and exploitation of novel targets.Industrial supervisor of CASE PhD Studentships and other collaborative projects working with leading academic researchers in major British Universities and Research Institutes.Influenced procedures for the maintenance of site safety acting in the role of Deputy BSO and secretary to the Genetic Manipulation Safety Committee.